Cartesian Therapeutics Seems A 'Strong Buy' After Positive Phase 2 Results
Cartesian Therapeutics(RNAC) Seeking Alpha·2024-09-17 21:45
Cartesian Therapeutics, Inc. (NASDAQ: RNAC ) focuses on mRNA-based cell therapies for autoimmune diseases and oncology. The company leverages its proprietary RNA Armory platform to engineer cells to produce therapeutic proteins. This technology supports autologous, allogeneic, and in vivo transfection, allowing accurate and My name is Myriam Hernandez Alvarez. I received the Electronics and Telecommunication Engineering degree from the Escuela Politecnica Nacional, Quito, Ecuador, the M.Sc. degree in comput ...